SCOPUS 정보 검색 플랫폼

Intensive Care Medicine

Volumn 40, Issue 10, 2014, Pages 1618-

De-escalation in severe sepsis: still an important part of our armamentarium against antimicrobial resistance

(2) Kapoor, Garima a Saigal, Saurabh b

a GANDHI MEDICAL COLLEGE (India)

b ALL INDIA INSTITUTE OF MEDICAL SCIENCES (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL SUPERINFECTION; DISEASE SEVERITY; HAND WASHING; HUMAN; INFECTION CONTROL; LENGTH OF STAY; LETTER; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY (TOPIC); PATIENT CARE; PERITONITIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SOFT TISSUE INFECTION; SURGICAL INFECTION; FEMALE; MALE; MORTALITY; SEPTIC SHOCK;

ANTI-BACTERIAL AGENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; SEPSIS; SHOCK, SEPTIC;

EID: 84919330498 PISSN: 03424642 EISSN: 14321238 Source Type: Journal
DOI: 10.1007/s00134-014-3476-4 Document Type: Letter

Times cited : (5)

References (4)

1
- 77954939129
- Recognition and prevention of multidrug-resistant gram negative bacteria in the intensive care unit
- PID: 20647792, COI: 1:CAS:528:DC%2BC3cXptV2ht74%3D
- Maragakis LL (2010) Recognition and prevention of multidrug-resistant gram negative bacteria in the intensive care unit. Crit Care Med 38(8 Suppl):S345–S351
- (2010) Crit Care Med , vol.38 , Issue.8 , pp. S345-S351
- Maragakis, L.L.¹

2
- 84873714375
- Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012
- PID: 23361625, COI: 1:STN:280:DC%2BC3szjs1Witw%3D%3D
- Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228
- (2013) Intensive Care Med , vol.39 , pp. 165-228
- Dellinger, R.P.¹ Levy, M.M.² Rhodes, A.³

3
- 84919392230
- De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
- Leone M, Bechis C, Baumstarck K et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.Intensive Care Med. doi:10.1007/s00134-014-3411-8
- (2014) Intensive Care Med
- Leone, M.¹ Bechis, C.² Baumstarck, K.³

4
- 84891026537
- De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
- PID: 24026297, COI: 1:STN:280:DC%2BC3sbnt1GmsA%3D%3D
- Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Márquez-Vácaro JA (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32–40
- (2014) Intensive Care Med , vol.40 , pp. 32-40
- Garnacho-Montero, J.¹ Gutiérrez-Pizarraya, A.² Escoresca-Ortega, A.³ Corcia-Palomo, Y.⁴ Fernández-Delgado, E.⁵ Herrera-Melero, I.⁶ Ortiz-Leyba, C.⁷ Márquez-Vácaro, J.A.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.